Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma

Vimentin expression predicts the occurrence of metastases in non small cell lung carcinomas

(2013) Maryline Dauphin et al.   LUNG CANCER

Beta-catenin expression is prognostic of improved non–small cell lung cancer survival

(2012) Connie G. Chiu et al.   AMERICAN JOURNAL OF SURGERY

Expression of Frat1 correlates with expression of β-catenin and is associated with a poor clinical outcome in human SCC and AC

(2012) Yong Zhang et al.   TUMOR BIOLOGY

Epithelial to Mesenchymal Transition Is a Determinant of Sensitivity to Chemoradiotherapy in Non-Small Cell Lung Cancer

(2011) Yasushi Shintani et al.   ANNALS OF THORACIC SURGERY

Epithelial to Mesenchymal Transition in an Epidermal Growth Factor Receptor-Mutant Lung Cancer Cell Line with Acquired Resistance to Erlotinib

(2011) Kenichi Suda et al.   Journal of Thoracic Oncology

Clinicopathological Significance of S100A4 Expression in Non-small Cell Lung Carcinomas

(2010) Eun Ah Jung et al.   Korean Journal of Pathology

China wrestles with lung cancer

(2010) Chihua Wen et al.   LANCET ONCOLOGY

TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma

(2010) M E Kupferman et al.   ONCOGENE

Expression of integrin-linked kinase in lung squamous cell carcinoma and adenocarcinoma: correlation with E-cadherin expression, tumor microvessel density and clinical outcome

(2010) Juanhan Yu et al.   VIRCHOWS ARCHIV

Expression of protein S100A4 is a predictor of recurrence in colorectal cancer

(2010) Jung Myun Kwak   WORLD JOURNAL OF GASTROENTEROLOGY

S100A4 and Metastasis

(2009) Kjetil Boye et al.   AMERICAN JOURNAL OF PATHOLOGY

Epithelial-mesenchymal transition in cancer development and its clinical significance

(2009) Masaaki Iwatsuki et al.   CANCER SCIENCE

Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression

(2009) D. L. Gibbons et al.   GENES & DEVELOPMENT

Biomarkers for epithelial-mesenchymal transitions

(2009) Michael Zeisberg et al.   JOURNAL OF CLINICAL INVESTIGATION

Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiL

(2009) Martin Reck et al.   JOURNAL OF CLINICAL ONCOLOGY

Pemetrexed in the treatment of advanced non-squamous lung cancer

(2009) Antonio Rossi et al.   LUNG CANCER

Upregulation of vimentin and aberrant expression of E-cadherin/β-catenin complex in oral squamous cell carcinomas: correlation with the clinicopathological features and patient outcome

(2009) Lai-Kui Liu et al.   MODERN PATHOLOGY

Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung

(2009) Ludmila Prudkin et al.   MODERN PATHOLOGY

Customized Treatment in Non-Small-Cell Lung Cancer Based on EGFR Mutations and BRCA1 mRNA Expression

(2009) Rafael Rosell et al.   PLoS One

The prognostic impact of NF-κB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer

(2008) S Al-Saad et al.   BRITISH JOURNAL OF CANCER

Cancer Statistics, 2008

(2008) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells

(2008) Sendurai A. Mani et al.   CELL

Prognostic Significance of Epithelial-Mesenchymal and Mesenchymal-Epithelial Transition Protein Expression in Non-Small Cell Lung Cancer

(2008) A. Soltermann et al.   CLINICAL CANCER RESEARCH

The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional RepressorsZEB1andZEB2

(2008) Manav Korpal et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer

(2008) Luigi De Petris et al.   LUNG CANCER